期刊文献+

Fractalkine对人外周血单个核细胞IL-8表达的影响及缬沙坦的干预作用

Effect of Fractalkine on IL-8 expression of monocytes in peripheral blood and the interventional effect of Valsartan
下载PDF
导出
摘要 目的观察趋化因子Fractalkine(FKN)对人血单个核细胞IL-8表达的影响,蛋白激酶C(PKC)在其中的作用,以及缬沙坦的干预效应。方法利用密度梯度离心法分离人外周血单个核细胞(PBMC);将提取的单个核细胞分5组,分别为:空白对照组、FKN组、Ro31-8220(PKC阻断剂)组、FKN+Ro31-8220组、FKN+缬沙坦组;各组PBMC分别在加药培养12 h和24 h后,用酶联免疫吸附实验(ELISA)法检测各组细胞培养液中的IL-8表达。结果 (1)细胞培养12 h或24 h后,与空白对照组相比,Ro31-8220组IL-8表达无明显差异(P>0.05);(2)FKN组较空白对照组IL-8表达明显减少(P<0.05),FKN+Ro31-8220较FKN组IL-8表达明显增加(P<0.05),FKN+缬沙坦组较FKN组IL-8表达明显减少(P<0.05)。(3)细胞培养24 h后,各组IL-8表达均较12h明显减少(P<0.05)。结论 FKN通过PKC途径抑制IL-8的表达,缬沙坦可加强这一抑制作用。 Objective To observe the effect of Fractalkine (FKN) on IL -8 expression of monocytes in peripheral blood and the function of Valsartan during the process. Methods Monocytes from fresh peripheral blood of healthy volunteers were isolated by the density gradient centrifugation. The monocytes isolated were divided into five groups: control, FKN, Ro31 -8220(PKC inhibitor), FKN + Ro31 -8220, FKN + Valsartan. The supernatants of monocytes were collected at 12 h and 24 h from each group. And the IL - 8 expressions of monocytes in every group were detected with ELISA. Results Compared with control group, IL -8 expressions decreased in FKN group (P 〈 0.05 ), while not significantlyin Ro31 - 8220 group (P 〉0.05). Compared with FKN group, IL- 8 expression increased in FKN + Ro31 -8220 group (P 〈 0. 05 ), while decreased in FKN + Valsartan group ( P 〈 0. 05 ) . After 24 h, IL - 8 expression in each group was significantly decreased than 12 h before (P 〈 0. 05 ). Conclusion FKN could inhibit IL - 8 expression in monocytes by PKC pathway. Valsartan may enhance the inhibition of FKN.
出处 《大连医科大学学报》 CAS 2015年第4期336-338,共3页 Journal of Dalian Medical University
基金 辽宁省科技厅资助项目(2011404013-6)
关键词 趋化因子(FKN) 蛋白激酶C(PKC) IL-8 缬沙坦 Fractalkine protein kinase C interleukin - 8 Valsartan
  • 相关文献

参考文献9

  • 1Jaipersad AS,Lip GYH,Silverman S,et al.The role of monocytes in angiogenesis and atherosclerosis[J].J Am Coll Cardiol,2014,63(1):1-11.
  • 2Frostegrd J.Immunity,atherosclerosis and cardiovascular disease[J].BMC Medicine,2013,11(1):117.
  • 3Ioannidis JP,Tzoulaki I.Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease[J].Circ Res,2012,110(5):658-662.
  • 4Yao K,Lu H,Huang R,et al.Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable anginapectoris:a preliminary report[J].Cardiovas Diabet,2011,10:50-59.
  • 5Samnegard A,HultheJ,Silveira A,et al.Gender speciticassociationsbetween matrix metalloproteinases and inflammatory markers in post myocardial unfarction patients[J].Atherosclerosis,2009,202(2):550-556.
  • 6Beaudeux J,Giral P,Bruclert E,et al.Matrix metallorapeutic perspectires[J].Clin Chem Lab Med,2004,42(2):121-131.
  • 7Steinberg SF.Cardiac actions of protein kinase C isoforms[J].Physiology: Bethesda,2012,27(3):130-139.
  • 8金元哲,雷明明,颜冰,张学颖,孙健.趋化因子FKN对人外周血单个核细胞IL-8表达的影响及ERK、PI3K和NF-κB在其中的作用[J].大连医科大学学报,2014,36(2):124-128. 被引量:3
  • 9Yang J,Jiang H,Yang J,et al.Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-κB signaling pathway[J].Mol Cell Biochem,2009,330(1-2):39-46.

二级参考文献17

  • 1Umehara H, Bollm ET, Okazaki T, et al. Fractalkine and vascular injury [J]. Trends Immunol, 2001,22 ( 11 ): 602 - 607.
  • 2Stolla M, Pelisek J, yon Brtihl ML, et al. Fractalkine is ex- pressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3 CR1 [ J ].PLoS One, 2012,7(8) : e43572.
  • 3Ikejima H, Imanishi T, Tsujioka H, et al. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris[J]. Circ J, 2010,74(2) : 337 - 345.
  • 4Yoneda O, Imai T, Gouda S, et al. Fractalkine - mediated endothelial cell injuryby NK Cells [ J ]. J Immunol, 2000, 164 ( 8 ) :4055 - 4062.
  • 5Guo X, Pan Y, Xiao C, et al. Fractalkine stimulates cell growth and increases its expression via NF - KB pathway inRA - FLS[J]. Int J Rheum Dis,2012, 15(3) :322 -329.
  • 6Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine ( CX3CL1 ) as an Amplification circuit of polarized Thl re- sponses [J]. J Clin Invest, 2001,107(9): 1173 -1181.
  • 7Elmas E, Lang S, Dempfle CE, et al. High plasma levels of tissue inhibitor of metalloproteinase - 1 ( TIMP - 1 ) and interleukin- 8 (IL- 8 ) characterize patients prone to ventricular fibrillation complicating myocardial infarction [ J]. Clin Chem Lab Med,2007,45 (10) :1360 - 1365.
  • 8Apadopoulou C, CorrigallV, Taylor PR, et al. The role of the ehemokines MCP - 1, GRO - alpha, IL - 8 and their receptors in the adhesion of monocytic cells to human ath- erosclerotic plaques [ J]. Cytokine, 2008,43 ( 2 ) : 181 - 186.
  • 9Jung SY, Choi SH, Yoo SY,et al. Modulation of Human Cardiac Progenitors via Hypoxia- ERK Circuit Improves their Functional Bioactivities [ J ]. Biomol Ther ( Seoul), 2013,21 (3) :196 -203.
  • 10Muslin AJ. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets [J]. Clin Sci (Loud) ,2008,115(7) :203 -218.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部